Solventum Corporation: shareholders and insiders

SOLVNYSEHealthcare · Surgical & Medical Instruments & Apparatus

Price

$88.65

November 16, 2026Market cap $15.4B

What Ploutos Investor adds for Solventum

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 4 fiscal years, from 2022
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 17, 2025 to Sep 3, 2026, from their own Form 4 filings.

2 Form 4s

Bought on the market

$100.3K

1 person

Sold on the market

–

nobody

From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 17, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $100.3K by 1 person·no sales

  • 2025: no buys, no sales
  • 2026: bought $100.3K by 1 person, no sales
  • Sep 1, 2026Bryan C HansonChief Executive Officer
    Kind
  • Sep 1, 2026Bryan C HansonChief Executive Officer
    Kind
  • Mar 10, 2026Amy McBride Wendell
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Aug 18, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by SOLV's officers and directors from 2025 up to November 16, 2025, 1 more calendar year

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 2 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%Apr 30, 2026 Latest filing
  • 3M Company
    Share of class14.8%
  • Independent Franchise Partners, LLP
    Share of class8.85%
  • Vanguard Capital Management
    Share of class6.27%
Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • The Vanguard Group0.00%Mar 27, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Jun 30, 2026 quarter end
  • Trian Fund Mgmt (Peltz)
    In the quarter
  • Bridgewater (Dalio)
    In the quarter×52.7
  • Millennium Mgmt (Englander)
    In the quarter+122%
  • D.E. Shaw
    In the quarter+261%
  • AQR Capital
    In the quarter+48%
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter-84%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 2.85% of its shares outstanding were held short, +1.2% since the report before.

Shares held short
4.95M
2.85%
Since the report before4.89M on Sep 30, 2026
+1.2%
4.7
1.05M
More days to cover thanof 4,578 US-listed companies with enough volume
57%
Report date
Oct 15, 2026
  • Apr 15, 2024: Shares held short 3.93M
  • Apr 30, 2024: Shares held short 4.10M
  • May 15, 2024: Shares held short 4.66M
  • May 31, 2024: Shares held short 5.95M
  • Jun 14, 2024: Shares held short 5.73M
  • Jun 28, 2024: Shares held short 5.23M
  • Jul 15, 2024: Shares held short 7.17M
  • Jul 31, 2024: Shares held short 6.42M
  • Aug 15, 2024: Shares held short 5.28M
  • Aug 30, 2024: Shares held short 5.35M
  • Sep 13, 2024: Shares held short 5.03M
  • Sep 30, 2024: Shares held short 4.69M
  • Oct 15, 2024: Shares held short 4.46M
  • Oct 31, 2024: Shares held short 3.80M
  • Nov 15, 2024: Shares held short 3.72M
  • Nov 29, 2024: Shares held short 3.61M
  • Dec 13, 2024: Shares held short 4.21M
  • Dec 31, 2024: Shares held short 4.40M
  • Jan 15, 2025: Shares held short 4.35M
  • Jan 31, 2025: Shares held short 4.45M
  • Feb 14, 2025: Shares held short 4.18M
  • Feb 28, 2025: Shares held short 4.29M
  • Mar 14, 2025: Shares held short 4.34M
  • Mar 31, 2025: Shares held short 4.22M
  • Apr 15, 2025: Shares held short 4.39M
  • Apr 30, 2025: Shares held short 4.13M
  • May 15, 2025: Shares held short 4.61M
  • May 30, 2025: Shares held short 4.50M
  • Jun 13, 2025: Shares held short 4.20M
  • Jun 30, 2025: Shares held short 4.40M
  • Jul 15, 2025: Shares held short 3.85M
  • Jul 31, 2025: Shares held short 3.77M
  • Aug 15, 2025: Shares held short 3.85M
  • Aug 29, 2025: Shares held short 4.27M
  • Sep 15, 2025: Shares held short 4.02M
  • Sep 30, 2025: Shares held short 3.90M
  • Oct 15, 2025: Shares held short 4.43M
  • Oct 31, 2025: Shares held short 4.95M
  • Nov 14, 2025: Shares held short 4.09M
  • Nov 28, 2025: Shares held short 3.69M
  • Dec 15, 2025: Shares held short 3.55M
  • Dec 31, 2025: Shares held short 4.05M
  • Jan 15, 2026: Shares held short 3.66M
  • Jan 30, 2026: Shares held short 3.66M
  • Feb 13, 2026: Shares held short 3.55M
  • Feb 27, 2026: Shares held short 3.49M
  • Mar 13, 2026: Shares held short 3.97M
  • Mar 31, 2026: Shares held short 5.38M
  • Apr 15, 2026: Shares held short 6.38M
  • Apr 30, 2026: Shares held short 6.48M
  • May 15, 2026: Shares held short 7.89M
  • May 29, 2026: Shares held short 7.58M
  • Jun 15, 2026: Shares held short 5.45M
  • Jun 30, 2026: Shares held short 5.02M
  • Jul 15, 2026: Shares held short 4.30M
  • Jul 31, 2026: Shares held short 3.51M
  • Aug 14, 2026: Shares held short 3.47M
  • Aug 31, 2026: Shares held short 4.30M
  • Sep 15, 2026: Shares held short 4.86M
  • Sep 30, 2026: Shares held short 4.89M
  • Oct 15, 2026: Shares held short 4.95M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading50.9% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 50.9% of the shares in the reported trades were short sales, against 50.6% in the 14 before.

Last 14 sessionsOct 28, 2026 – Nov 16, 2026
50.9%
The 14 beforeOct 8, 2026 – Oct 27, 2026
50.6%
Change
+0.3 pts
Short sales a dayon average, of 479.6K shares
244.0K
More than atof 3,668 US-listed companies, same days
52%
Median of alleight in ten from 34.7% to 63.8%
50.3%
  • Oct 8, 2026: Short sales 42.5%
  • Oct 9, 2026: Short sales 56.8%
  • Oct 12, 2026: Short sales 47.3%
  • Oct 13, 2026: Short sales 50.6%
  • Oct 14, 2026: Short sales 59.3%
  • Oct 15, 2026: Short sales 41.9%
  • Oct 16, 2026: Short sales 38.5%
  • Oct 19, 2026: Short sales 62.6%
  • Oct 20, 2026: Short sales 64.2%
  • Oct 21, 2026: Short sales 63%
  • Oct 22, 2026: Short sales 60.6%
  • Oct 23, 2026: Short sales 34.2%
  • Oct 26, 2026: Short sales 64.1%
  • Oct 27, 2026: Short sales 54.2%
  • Oct 28, 2026: Short sales 53%
  • Oct 29, 2026: Short sales 48%
  • Oct 30, 2026: Short sales 43.4%
  • Nov 2, 2026: Short sales 64.9%
  • Nov 3, 2026: Short sales 66.2%
  • Nov 4, 2026: Short sales 36.2%
  • Nov 5, 2026: Short sales 35.8%
  • Nov 6, 2026: Short sales 61.8%
  • Nov 9, 2026: Short sales 48.7%
  • Nov 10, 2026: Short sales 43.7%
  • Nov 11, 2026: Short sales 31.8%
  • Nov 12, 2026: Short sales 67.7%
  • Nov 13, 2026: Short sales 55.8%
  • Nov 16, 2026: Short sales 47.5%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

25.76M Insiders' shares14.85% Of the company
  • 3m CoTenPercentOwner
    Directly25.57M
  • Bryan C HansonChief Executive Officer
    Directly185.5K
  • Amy McBride WendellDirector
    Directly5,039

A lower bound: it counts only the 3 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

Executive pay

From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.

2025 Latest year2 Years on record

$20M

Actually paid: $40M

$5.1M

Actually paid: $6.9M

$115

Peers: $109

Constant Currency Revenue

$8.4B

From the proxy statement (DEF 14A) of Mar 27, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A

Share repurchases

How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.

$355M Repurchases over 2 quarters$645M Left in the program
  • Jun 30, 202610-Q
    Amount$288M
  • Mar 31, 202610-Q
    Amount$67M

From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price.

The shareholders' vote on pay

The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.

74.2% For in 20262 Votes on record
  • 2026May 20, 2026
    For
    74.2%
  • 2025May 2, 2025
    For
    85.9%

From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

32 ETFs holding it0.24% The largest weight (VBR)
  • VBRVanguard Small-Cap Value Index Fund
    Weight in the fund0.24%
  • IYHiShares U.S. Healthcare ETF
    Weight in the fund0.21%
  • RSPInvesco S&P 500 Equal Weight ETF
    Weight in the fund0.20%
  • XLVState Street(R) Health Care Select Sector SPDR(R) ETF
    Weight in the fund0.20%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.19%
  • IXJiShares Global Healthcare ETF
    Weight in the fund0.15%
  • VBVanguard Small-Cap Index Fund
    Weight in the fund0.14%
  • SPHQInvesco S&P 500 Quality ETF
    Weight in the fund0.13%
  • IWSiShares Russell Mid-Cap Value ETF
    Weight in the fund0.11%
  • IWRiShares Russell Mid-Cap ETF
    Weight in the fund0.08%

32 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

878 Managers, Q2 2026$9.8B Value of their positions
  • Q3 2025: Managers 871
  • Q4 2025: Managers 942
  • Q1 2026: Managers 886
  • Q2 2026: Managers 878

Institutional investors by quarter

The fund managers holding SOLV, quarter by quarter, from Q1 2024 to Q2 2025, 6 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 10 quarters.

Q2 2026: 878 managers held 128M shares, worth $9.8B. During the quarter 119 opened a position, 127 closed one, 247 added and 279 trimmed.

The largest holders, Q2 2026

  • Independent Franchise Partners
    In the quarter+2.8%
  • BlackRock
    In the quarter-6.8%
  • Vanguard Capital Management
    In the quarter+0.2%
  • Trian Fund Mgmt (Peltz)
    In the quarter
  • Vanguard Portfolio Management
    In the quarter-1.0%
  • Davis Selected Advisers
    In the quarter-0.4%
  • State Street
    In the quarter-12%
  • Geode Capital Management
    In the quarter+3.3%
  • Boston Partners
    In the quarter+3.2%
  • Invesco
    In the quarter-13%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

The full analysis

What do Solventum's filings show?

Who buys and sells is one part of Solventum's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about SOLV's shareholders

Didn't find what you were looking for?

Ask us
Have SOLV's insiders bought or sold?

From Aug 18, 2026 to Sep 3, 2026 Solventum's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold SOLV?

7 of the managers we track held the shares on Jun 30, 2026. The largest position was Trian Fund Mgmt (Peltz)'s, worth $636M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.